drugset

drugset / Trial / NCT02274610

Pharmacokinetic Study of Docetaxel-PNP and Taxotere to Treat Patient With Advanced Solid Cancer

NCT02274610 ↗

Phase 1 Completed 18 enrolled Samyang Biopharmaceuticals Corporation

RandomizedCrossoverOpen-labelTreatment

Summary

Evaluation of the pharmacokinetic equivalence of two Docetaxel formulations in terms of AUC and Cmax

Timeline

Start: 2014-11
Primary completion: 2015-11
Completion: 2015-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Docetaxel	Small molecule	—	—

Indications